Showing results (1-10 of 23) with videos related to
Sort By:
Pageof 3
Artificial Intelligence in Medicine|February 25, 2006
Statistical analysis of combined dose effects for experiments with two agentsStefan Wagenpfeil, Uwe Treiber, Antonie LehmerUrologic Oncology|March 11, 2011
Imaging of prostate cancer with PET/CT and radioactively labeled choline derivatesBernd Joachim Krause, Michael Souvatzoglou, Uwe TreiberEuropean Journal of Cancer (Oxford, England : 1990)|September 12, 2008
Metastatic renal cell carcinoma: results of a population-based study with 25 years follow-upAnne Schlesinger-Raab, Uwe Treiber, Dirk Zaak, et al.The Journal of Urology|March 20, 2012
Gender and body mass index as risk factors for bladder perforation during primary transurethral resection of bladder tumorsKathleen Herkommer, Christian Hofer, Juergen E Gschwend, et al.Anticancer Research|September 12, 2013
Utility of ATP7B in prediction of response to platinum-based chemotherapy in urothelial bladder cancerSebastian Christoph Schmid, Tibor Schuster, Thomas Horn, et al.Applied Immunohistochemistry & Molecular Morphology : AIMM|March 1, 2003
Immunohistochemical assessment of a testicular tumor in a 63-year-old patient: proposal for an integrated clinicopathologic approachGregor Weirich, Jörg Nährig, Uwe Treiber, et al.European Journal of Nuclear Medicine and Molecular Imaging|April 9, 2009
Characterization of choline uptake in prostate cancer cells following bicalutamide and docetaxel treatmentSebastian A Müller, Korbinian Holzapfel, Christof Seidl, et al.Urologia Internationalis|June 10, 2009
Influence of body mass index on operability, morbidity and disease outcome following radical cystectomyTobias Maurer, Jean Maurer, Margitta Retz, et al.Anticancer Research|November 17, 2012
Nuclear matrix protein 22 for bladder cancer detection: comparative analysis of the BladderChek® and ELISAGeorgios Hatzichristodoulou, Hubert Kübler, Hartwig Schwaibold, et al.The Prostate|December 24, 2004
In vitro cytotoxic effects of imatinib in combination with anticancer drugs in human prostate cancer cell linesHubert R Kübler, Heiner van Randenborgh, Uwe Treiber, et al.Pageof 3